Why Exelixis Stock Broke Down in October
Shares of cancer specialist Exelixis (NASDAQ: EXEL) dropped by 12.6% in October, according to data from S&P Global Market Intelligence.
Why did investors hit the exits last month? Despite a strong month for biotech stocks in general, Exelixis' shares were essentially trading sideways over the course of October -- that is, up until the company reported its third-quarter earnings after the bell on Oct. 30. Shares promptly dropped by 10% during the next day's trading session.
Image source: Getty Images.
Source Fool.com
